Download PDF
Thromb Haemost 2019; 119(12): 1994-2004
DOI: 10.1055/s-0039-1696972
Cellular Haemostasis and Platelets
Georg Thieme Verlag KG Stuttgart · New York

Premorbid Hemostasis in Women with a History of Pregnancy Loss

Alina D. Peshkova
1   Kazan Federal University, Kazan, Russia
,
Svetlana I. Safiullina
2   Kazan State Medical University, Kazan, Russia
3   Medical Center “Aibolit,” Kazan, Russia
,
Natalia G. Evtugina
1   Kazan Federal University, Kazan, Russia
,
Yelena S. Baras
4   Dar a Luz Birth and Health Center, Albuquerque, New Mexico, United States
,
Fazoil I. Ataullakhanov
5   Center for Theoretical Problems of Physico-Chemical Pharmacology, Russian Academy of Sciences, Moscow, Russia
,
John W. Weisel
6   School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States
,
Rustem I. Litvinov
1   Kazan Federal University, Kazan, Russia
6   School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States
› Author Affiliations Funding This work was supported by NIH grants HL135254, U01HL116330, NSF grant DMR1505662, the Program for Competitive Growth at Kazan Federal University, grants 19–015–00075, 18–415–160004, and 19–51–15004 from the Russian Foundation for Basic Research, a grant of the Ministry of Science and Higher Education of the Russian Federation (project АААА-А18–118012390250–0), and a grant of the Presidium of the Russian Academy of Sciences (the Program for fundamental research “Fundamentals of the technology of physiological adaptations”).
Further Information

Publication History

23 May 2019

19 July 2019

Publication Date:
06 October 2019 (online)

    Permissions and Reprints

Abstract

Background Congenital and acquired hemostatic disorders are among the pathogenic factors of pregnancy loss. Studying mechanistic relations between impaired hemostasis and fetal losses is important for the prognosis and prophylaxis of obstetric complications.

Objective This article aims to establish latent hemostatic disorders in nonpregnant women as an important premorbid risk factor of pregnancy loss.

Methods and Results Hemostasis was characterized using two relatively new in vitro assays, namely thrombodynamics (spatial clot growth) and kinetics of blood clot contraction, which together reflect the hemostatic or thrombotic potential. In addition, platelet functionality was assessed using flow cytometry. Our study included 50 women with a history of pregnancy loss and 30 parous women without previous obstetric complications. In patients with pregnancy loss, hypercoagulability was observed along with significant impairment of blood clot contraction associated with chronic platelet activation and dysfunction. Both hypercoagulability and defective clot contraction were significantly more pronounced in patients with a history of three or more miscarriages compared with patients with a history of one or two miscarriages. In addition, a significant inhibition of clot contraction was found in patients with miscarriage occurring after 10 weeks of gestation compared with those who lost a fetus earlier in pregnancy.

Conclusion These results indicate that chronic hypercoagulability and impaired clot contraction constitute a premorbid status in patients with pregnancy loss. The data confirm a significant pathogenic role of hemostatic disorders in pregnancy loss and suggest the predictive value of thrombodynamics and blood clot contraction assays in evaluating the risk of pregnancy loss.

Keywords

blood clotting - contraction of blood clots - recurrent pregnancy loss - miscarriage

Authors' Contributions

R.I.L., S.I.S., F.I.A., and J.W.W designed the research; A.D.P. and N.G.E. performed experiments; A.D.P., S.I.S., Y.S.B., F.I.A., J.W.W., and R.I.L. analyzed the data; A.D.P., J.W.W., and R.I.L. wrote the paper.


Supplementary Material

 

  • References

  • 1 Kolte AM, Bernardi LA, Christiansen OB. , et al; ESHRE Special Interest Group, Early Pregnancy. Terminology for pregnancy loss prior to viability: a consensus statement from the ESHRE early pregnancy special interest group. Hum Reprod 2015; 30 (03) 495-498
    CrossrefPubMedGoogle Scholar
  • 2 Ford HB, Schust DJ. Recurrent pregnancy loss: etiology, diagnosis, and therapy. Rev Obstet Gynecol 2009; 2 (02) 76-83
    PubMedGoogle Scholar
  • 3 Practice Committee of the American Society for Reproductive Medicine. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril 2012; 98 (05) 1103-1111
    CrossrefPubMedGoogle Scholar
  • 4 de Jong PG, Goddijn M, Middeldorp S. Testing for inherited thrombophilia in recurrent miscarriage. Semin Reprod Med 2011; 29 (06) 540-547
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Shahine L, Lathi R. Recurrent pregnancy loss: evaluation and treatment. Obstet Gynecol Clin North Am 2015; 42 (01) 117-134
    CrossrefPubMedGoogle Scholar
  • 6 Bennett SA, Bagot CN, Appiah A. , et al. Women with unexplained recurrent pregnancy loss do not have evidence of an underlying prothrombotic state: experience with calibrated automated thrombography and rotational thromboelastometry. Thromb Res 2014; 133 (05) 892-899
    CrossrefPubMedGoogle Scholar
  • 7 Soshitova NP, Karamzin SS, Balandina AN. , et al. Predicting prothrombotic tendencies in sepsis using spatial clot growth dynamics. Blood Coagul Fibrinolysis 2012; 23 (06) 498-507
    CrossrefPubMedGoogle Scholar
  • 8 Sinauridze EI, Gorbatenko AS, Seregina EA, Lipets EN, Ataullakhanov FI. Moderate plasma dilution using artificial plasma expanders shifts the haemostatic balance to hypercoagulation. Sci Rep 2017; 7 (01) 843
    CrossrefPubMedGoogle Scholar
  • 9 Tutwiler V, Litvinov RI, Lozhkin AP. , et al. Kinetics and mechanics of clot contraction are governed by the molecular and cellular composition of the blood. Blood 2016; 127 (01) 149-159
    CrossrefPubMedGoogle Scholar
  • 10 utwiler V, Peshkova AD, Andrianova IA, Khasanova DR, Weisel JW, Litvinov RI. Contraction of blood clots is impaired in acute ischemic stroke. Arterioscler Thromb Vasc Biol 2017; 37 (02) 271-279
    CrossrefPubMedGoogle Scholar
  • 11 Peshkova AD, Malyasev DV, Bredikhin RA. , et al. Contraction of blood clots is impaired in deep vein thrombosis. Bionanoscience 2016; 6: 457-459
    CrossrefPubMedGoogle Scholar
  • 12 Le Minh G, Peshkova AD, Andrianova IA. , et al. Impaired contraction of blood clots as a novel prothrombotic mechanism in systemic lupus erythematosus. Clin Sci (Lond) 2018; 132 (02) 243-254
    CrossrefPubMedGoogle Scholar
  • 13 Peshkova AD, Malyasyov DV, Bredikhin RA. , et al. Reduced contraction of blood clots in patients with venous thromboembolism is a possible thrombogenic and embologenic mechanism. TH Open 2018; 2 (01) e104-e115
    Article in Thieme ConnectPubMedGoogle Scholar
  • 14 Dundar O, Pektas MK, Bodur S, Bakır LV, Cetin A. Recurrent pregnancy loss is associated with increased red cell distribution width and platelet distribution width. J Obstet Gynaecol Res 2015; 41 (04) 551-558
    CrossrefPubMedGoogle Scholar
  • 15 Budzianowski J, Pieszko K, Burchardt P, Rzeźniczak J, Hiczkiewicz J. The role of hematological indices in patients with acute coronary syndrome. Dis Markers 2017; 2017: 3041565
    PubMedGoogle Scholar
  • 16 Rai R, Tuddenham E, Backos M. , et al. Thromboelastography, whole-blood haemostasis and recurrent miscarriage. Hum Reprod 2003; 18 (12) 2540-2543
    CrossrefPubMedGoogle Scholar
  • 17 Bick RL, Hoppensteadt D. Recurrent miscarriage syndrome and infertility due to blood coagulation protein/platelet defects: a review and update. Clin Appl Thromb Hemost 2005; 11 (01) 1-13
    CrossrefPubMedGoogle Scholar
  • 18 Réger B, Péterfalvi A, Litter I. , et al. Challenges in the evaluation of D-dimer and fibrinogen levels in pregnant women. Thromb Res 2013; 131 (04) e183-e187
    CrossrefPubMedGoogle Scholar
  • 19 Szecsi PB, Jørgensen M, Klajnbard A, Andersen MR, Colov NP, Stender S. Haemostatic reference intervals in pregnancy. Thromb Haemost 2010; 103 (04) 718-727
    Article in Thieme ConnectPubMedGoogle Scholar
  • 20 Pasquier E, De Saint Martin L, Bohec C, Collet M, Dignat George F, Mottier D. Unexplained pregnancy loss: a marker of basal endothelial dysfunction?. Fertil Steril 2013; 100 (04) 1013-1017
    CrossrefPubMedGoogle Scholar
  • 21 Lukanov TH, Veleva GL, Konova EI, Ivanov PD, Kovacheva KS, Stoykov DJ. Levels of platelet-leukocyte aggregates in women with both thrombophilia and recurrent pregnancy loss. Clin Appl Thromb Hemost 2011; 17 (02) 181-187
    CrossrefPubMedGoogle Scholar
  • 22 Gerhardt A, Scharf RE, Greer IA, Zotz RB. Hereditary risk factors for thrombophilia and probability of venous thromboembolism during pregnancy and the puerperium. Blood 2016; 128 (19) 2343-2349
    CrossrefPubMedGoogle Scholar
  • 23 Ke RW. Endocrine basis for recurrent pregnancy loss. Obstet Gynecol Clin North Am 2014; 41 (01) 103-112
    CrossrefPubMedGoogle Scholar
  • 24 Kitaya K, Matsubayashi H, Takaya Y. , et al. Live birth rate following oral antibiotic treatment for chronic endometritis in infertile women with repeated implantation failure. Am J Reprod Immunol 2017; 78 (05) e12719
    PubMedGoogle Scholar
  • 25 Naser HA, Ibrahem AF, Hashim HA. Basophil count as predictor to the deep vein thrombosis and the thrombo-embolization. Muthanna Med. J. 2018; 5: 95-106
    PubMedGoogle Scholar
  • 26 Glueck CJ, Kupferminc MJ, Fontaine RN, Wang P, Weksler BB, Eldor A. Genetic hypofibrinolysis in complicated pregnancies. Obstet Gynecol 2001; 97 (01) 44-48
    PubMedGoogle Scholar
  • 27 Bigdeli R, Younesi MR, Panahnejad E. , et al. Association between thrombophilia gene polymorphisms and recurrent pregnancy loss risk in the Iranian population. Syst Biol Reprod Med 2018; 64 (04) 274-282
    CrossrefPubMedGoogle Scholar
  • 28 Adler G, Mahmutbegovic E, Valjevac A. , et al. Association between – 675 ID, 4G/5G PAI-1 gene polymorphism and pregnancy loss: f systematic review. Acta Inform Med 2018; 26 (03) 156-159
    CrossrefPubMedGoogle Scholar
  • 29 Magdoud K, Herbepin VG, Touraine R, Almawi WY, Mahjoub T. Plasminogen activator inhibitor 1 4G/5G and -844G/A variants in idiopathic recurrent pregnancy loss. Am J Reprod Immunol 2013; 70 (03) 246-252
    CrossrefPubMedGoogle Scholar
  • 30 Goodman CS, Coulam CB, Jeyendran RS, Acosta VA, Roussev R. Which thrombophilic gene mutations are risk factors for recurrent pregnancy loss?. Am J Reprod Immunol 2006; 56 (04) 230-236
    CrossrefPubMedGoogle Scholar
  • 31 Subrt I, Ulcova-Gallova Z, Cerna M. , et al. Recurrent pregnancy loss, plasminogen activator inhibitor-1 (-675) 4G/5G polymorphism and antiphospholipid antibodies in Czech women. Am J Reprod Immunol 2013; 70 (01) 54-58
    CrossrefPubMedGoogle Scholar